AUMED, a.s. successfully completed the project entitled “Transfer factor TFI – Medicinal product”

AUMED, a.s. successfully completed the project entitled “Transferfaktor TFI – Medicinal product”, registration number CZ.01.1.02/0.0/0.0/20_318/0026008.

As part of the project, a selection procedure was carried out for suppliers of modifications, technologies and devices in accordance with the rules of OP PIK while respecting the conditions of equal opportunities, non-discriminatory and transparent selection of suppliers. Investments were made in long-term tangible assets, both in the “production technology” and “control” sections. PQ level qualifications have been carried out for facilities where legislation requires it. All planned innovations were achieved.

The goal of the project was the creation of a new production and control center of AUMED, a.s., which will use the results of its own R&D for the production of an innovative product based on transfer factor (TFI). The project received financial support from the EU within the Operational Program Entrepreneurship and Innovation for Competitiveness, Innovation Challenges – Innovation Project – Challenge VIII.